首页> 美国卫生研究院文献>other >Systematic Analysis of Gene Expression Alterations and Clinical Outcomes for Long-Chain Acyl-Coenzyme A Synthetase Family in Cancer
【2h】

Systematic Analysis of Gene Expression Alterations and Clinical Outcomes for Long-Chain Acyl-Coenzyme A Synthetase Family in Cancer

机译:癌症中长链酰基辅酶A合成酶家族的基因表达改变和临床结果的系统分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Dysregulated lipid metabolism contributes to cancer progression. Our previous study indicates that long-chain fatty acyl-Co A synthetase (ACSL) 3 is essential for lipid upregulation induced by endoplasmic reticulum stress. In this report, we aimed to identify the role of ACSL family in cancer with systematic analysis and in vitro experiment. We explored the ACSL expression using Oncomine database to determine the gene alteration during carcinogenesis and identified the association between ACSL expression and the survival of cancer patient using PrognoScan database. ACSL1 may play a potential oncogenic role in colorectal and breast cancer and play a potential tumor suppressor role in lung cancer. Co-expression analysis revealed that ACSL1 was coexpressed with MYBPH, PTPRE, PFKFB3, SOCS3 in colon cancer and with LRRFIP1, TSC22D1 in lung cancer. In accordance with PrognoScan analysis, downregulation of ACSL1 in colon and breast cancer cell line inhibited proliferation, migration, and anchorage-independent growth. In contrast, increase of oncogenic property was observed in lung cancer cell line by attenuating ACSL1. High ACSL3 expression predicted a better prognosis in ovarian cancer; in contrast, high ACSL3 predicted a worse prognosis in melanoma. ACSL3 was coexpressed with SNUPN, TRIP13, and SEMA5A in melanoma. High expression of ACSL4 predicted a worse prognosis in colorectal cancer, but predicted better prognosis in breast, brain and lung cancer. ACSL4 was coexpressed with SERPIN2, HNRNPCL1, ITIH2, PROCR, LRRFIP1. High expression of ACSL5 predicted good prognosis in breast, ovarian, and lung cancers. ACSL5 was coexpressed with TMEM140, TAPBPL, BIRC3, PTPRE, and SERPINB1. Low ACSL6 predicted a worse prognosis in acute myeloid leukemia. ACSL6 was coexpressed with SOX6 and DARC. Altogether, different members of ACSLs are implicated in diverse types of cancer development. ACSL-coexpressed molecules may be used to further investigate the role of ACSL family in individual type of cancers.
机译:脂质代谢失调会导致癌症进展。我们以前的研究表明,长链脂肪酰基辅酶A合成酶(ACSL)3对于内质网应激诱导的脂质上调至关重要。在本报告中,我们旨在通过系统分析和体外实验确定ACSL家族在癌症中的作用。我们使用Oncomine数据库探索了ACSL表达,以确定癌变过程中的基因改变,并使用PrognoScan数据库确定了ACSL表达与癌症患者生存之间的关联。 ACSL1可能在结直肠癌和乳腺癌中起潜在的致癌作用,并在肺癌中起潜在的抑癌作用。共表达分析表明,ACSL1在结肠癌中与MYBPH,PTPRE,PFKFB3,SOCS3共表达,在肺癌中与LRRFIP1,TSC22D1共表达。根据PrognoScan分析,结肠癌和乳腺癌细胞系中ACSL1的下调抑制了增殖,迁移和锚定非依赖性生长。相反,通过减弱ACSL1,在肺癌细胞系中观察到致癌性增加。 ACSL3高表达预示卵巢癌预后更好。相反,高ACSL3预测黑色素瘤的预后较差。 ACSL3与SNUPN,TRIP13和SEMA5A在黑色素瘤中共表达。 ACSL4的高表达预示着结直肠癌预后较差,但预示乳腺癌,脑癌和肺癌预后较好。 ACSL4与SERPIN2,HNRNPCL1,ITIH2,PROCR,LRRFIP1共表达。 ACSL5的高表达预示着乳腺癌,卵巢癌和肺癌的良好预后。 ACSL5与TMEM140,TAPBPL,BIRC3,PTPRE和SERPINB1共表达。低ACSL6预测急性髓性白血病的预后较差。 ACSL6与SOX6和DARC共表达。总而言之,ACSL的不同成员与多种类型的癌症发展有关。 ACSL共表达的分子可用于进一步研究ACSL家族在个别类型癌症中的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号